Schizophrenia is a complex psychiatric disorder with unknown and presumably heterogeneous etiology. While the disorder can have various outcomes, research is predominantly "deficitoriented" emphasizing the hardship that the disorder inflicts on sufferers as well as their families and society. Beyond symptom reduction, imparting patients with hope and meaning in life is increasingly considered an important treatment target, which may raise self-esteem, and reduce self-stigma and suicidal ideation. The present study compared a psychotherapeutic treatment aimed at improving cognitive insight, individualized metacognitive intervention (MCT+), with an active control in order to elucidate if personal meaningmaking and hope can be improved in patients with psychosis across time. A total of 92 patients were randomized to either individualized metacognitive therapy (MCT+) or CogPack (neuropsychological training) and followed up for up to 6 months. The "Subjective Sense in Psychosis Questionnaire" (SUSE) was administered which covers different salutogenetic vs pathogenetic views of the disorder, valence of symptom experiences and the consequences of psychosis. Patients in the MCT+ group showed a significant positive shift in attitudes towards the consequences of their illness over time relative to patients in the active control condition. There was some evidence that MCT+ also enhanced meaning-making. The perceived negative consequences of psychosis were highly correlated with depression and low self-esteem, as well as suicidality. The study shows that a cognitive insight training can improve meaning-making in patients and help them come to terms with their diagnosis.
Introduction
Schizophrenia is a psychiatric disorder with an often chronic course. 1, 2 A plethora of studies suggests that psychosis is associated with increased risk for suicide, 3 poor functional outcome, 4, 5 and high societal costs. 6 The over-emphasis of the negative consequences of psychosis and biological impairment 7 and genetic involvement 8 foster stigma, decrease hope/treatment engagement, and lead to pessimism 9, 10 and thus aggravate symptomatology. Factors that represent resources for patients with other disorders, such as higher education and insight, are among the best predictors for later suicide in psychotic disorders, 3 tentatively indicating that being well-informed about the disorder and how it is portrayed is detrimental to well-being.
The well-established tendency to present averaged results 11 obscures the vast heterogeneity of the disorder in terms of etiology, course, and self-appraisal. Of note, there is a considerable subgroup of patients with a more benign course who achieve remission or even recovery. 2, 12, 13 It has been estimated that 10%-25% of patients present only one psychotic episode. [14] [15] [16] Only around 20% have chronic symptoms and disability. In Europe, 10%-30% of individuals with schizophrenia have stable employment, 17, 18 with considerable variation across countries 19 ; 12%-39% of patients are able to work at least part time. 20 The overstatement of the negative consequences of the disorder dates back to earlier times. Kraepelin did not change his pessimistic view about the general course of "dementia praecox", 21 although a considerable proportion of his patients fully recovered. More recently, the concept of recovery has received growing acceptance. Personal recovery has moved beyond mere symptom reduction and is understood as living a satisfying and meaningful life with the disorder, having a valued role and positive perspective, 22 even in the presence of persistent symptoms. 23 Recovery involves deeply subjective changes including recapturing the ability to make sense of the challenges that are posed by and accompany serious mental illness. 24 Many people with psychosis also describe recovery as finding a sense of self coherence and personal meaning in the world that allows for hope and the restoration of a sense of personal dignity. 25 Patients have different ways to cope with their diagnosis and most of them experience symptoms with marked ambivalence. 26, 27 In a recent study, we found that the negative appraisal of symptoms clearly prevailed when looking at mean values. 27 Yet, only a minority of patients regarded their symptoms as purely negative. Most had mixed attitudes. A minority even sees their symptoms in a predominantly positive light, eg, voices as companions and social surrogates.
The above presents a serious challenge for clinical practice. Highlighting the negative consequences of psychosis, which might instill motivation to change if effective treatment options are available, will likely foster fatalism and lower quality of life in cases in which medication and psychotherapy for psychosis are only partially effective (both medication treatment 28 and psychotherapy 29 exert medium effects on symptoms at best, such that many patients remain unable to work and participate socially 30 even after significant symptom decline, for algorithms defining remission and recovery see 31 ). In contrast, exaggerating the probability of full recovery and strong optimism with respect to the course of the disorder might be viewed as playing with fire as it could decrease insight and self-reflectiveness to the extent that important early signs of relapse go unnoticed.
The multitude of attitudes that patients may have towards their symptoms and diagnosis is not captured by standard scales such as quality of life instruments. Recently, the "Subjective Sense in Psychosis Questionnaire" (SUSE) has been devised. 26 It captures different attitudes of patients across 2 extreme poles: Psychoses as completely meaningless and random events vs psychotic experiences as reflecting unconscious experiences and conflicts. The original version consists of 6 subscales targeting the salutogenetic/pathogenetic understanding of patients how they relate the disorder to their life experiences ("biographical integration"), experience of symptoms and the consequences of the disorder. The development of the scale was stimulated by evidence that recovery from psychotic crises is moderated by patients' ability to find some sense and meaning in their disorder. 22, 32, 33 The present study investigated how individualized metacognitive therapy (MCT+), 34, 35 which blends elements of cognitive behavioral therapy (CBT) with metacognitive training (MCT), impacts patients' views of their disorder. The training addresses both cognitive biases, particularly jumping to conclusions 36, 37 and overconfidence, 38, 39 as well as dysfunctional emotion regulation strategies. [40] [41] [42] While MCT+ emphasizes that these traps are universal and not confined to patients (ie, normalization), their significance is by no means downplayed and it is stressed how an escalation of these biases and dysfunctional strategies induces symptoms. 43 To this end, a deviation from normal functioning rather than an (incomprehensible) abnormality is conveyed, in the hope of fostering change without creating stigma. Patients are also taught how to detect future relapses and to connect their biography and major life events in their concept of illness. Finally, it also addresses ways to cope with common prejudices against psychosis and when and how to communicate the disorder.
The study is part of a larger trial which showed that MCT+ leads to faster gains in symptom improvement than an active control intervention. 44 We were interested to see whether subjective meaning and personal narratives are altered by a psychotherapeutic approach, such as MCT+. While research on MCT has tended to focus on remission of positive symptoms, especially delusions, this form of treatment might also lead to more subjective forms of recovery, in a manner similar to metacognitive reflective insight therapy (MERIT). 45, 46 Individualized MCT and other cognitive insight treatments may help patients to make better sense of who they are as unique beings in the world, which may enable them to pursue a meaningful life. This is consistent with qualitative analyses of MERIT, which suggest that a metacognitive approach promotes narrative coherence and a sense of agency.
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Methods
Data for the present study were collected in the context of a previously published monocentric randomized controlled trial (RCT), which was carried out at the Department of Psychiatry and Psychotherapy of the University Medical Center Hamburg-Eppendorf (Germany). The characteristics and main findings of the trial are reported elsewhere 44 and will be summarized here for readers' convenience.
A total of 92 patients fulfilling DSM-IV criteria for a schizophrenia spectrum disorder as confirmed with the Mini Neuropsychiatric Interview (M.I.N.I.) 48 and current or past delusions were recruited from the inpatient and outpatient facilities of the institution. All patients were between 18 to 65 years old. Exclusion criteria were kept to a minimum in order to ensure the generalizability of findings. A primary diagnosis of substance use disorder, IQ < 70, as assessed with a vocabulary test, 49 severe organic brain disorders, previous experience with group MCT or MCT+ (concurrent group MCT was tolerated, see below) or CRT, and any ongoing CBT-oriented psychotherapy led to exclusion. Other comorbid disorders were tolerated. The trial was approved by the ethics committee of the German Psychology Association (DGPs). All patients gave their written informed consent before participation. Figure 1 displays the CONSORT flow chart diagram.
All patients were randomized according to a computerized randomization plan to either (1) MCT+, 34 ,35,43 a manualized 12-session intervention (manual available at no cost via www.uke.de/mct_plus in several languages), which aims to highlight the fallibility of cognition in general and encourage patients to reflect on their own thinking styles in relation to symptoms and everyday life and includes modules addressing cognitive biases, self-esteem, coping with stigma/stress and emotional problems; or (2) CogPack, 50 a computerized cognitive training program that targets common cognitive dysfunctions in patients with psychosis and was delivered in 12 sessions, so that the 2 interventions were roughly matched for therapeutic effort. Treatment allocation was performed observer-blind and communicated to patients by a person who was neither involved in the assessments nor in the delivery of the intervention. The study was conceptualized as an add-on study; the treatments did not interfere with any standard treatment including medication and group MCT, as the latter represents a standard treatment in our department. Thus, patients from both conditions could participate in MCT groups.
Patients were assessed at 3 points in time: baseline, after 6 weeks (T1, corresponding to completion of the maximum of 12 intervention sessions) and 6 months later (T2). All assessments were carried out by raters blind to treatment allocation following an extensive rater training. It was ensured that assessments for each individual patient were carried out by the same rater throughout the trial period and that raters worked at different times than therapists to ensure blindness.
Outcomes
Psychopathology. Results of the primary outcomes are presented elsewhere. 44 Main outcomes of the RCT included Psychotic Symptom Rating Scales (PSYRATS) 51, 52 and Positive and Negative Syndrome Scale (PANSS) 53 scores.
Subjective Sense in Psychosis Questionnaire. The SUSE 26 measures distinct aspects of the experience and meaning of psychoses within 5 coherent subscales representing positive and negative meanings in the course of psychotic disorders (on 3 time-levels: past, present experience and future expectations). The scale was developed in the context of a trialogue research project 54 which involved the collaboration with individuals with psychosis experience and relatives. The scale has been revised several times 55 and has good psychometric properties. 26 The shortened version applied in this trial consists of 28 items, answered on a 4-point Likert scale, with 5 subscales: biographical integration (formerly called emergence of psychosis), positive (enriching) experience of symptoms, negative (burdening) experience of symptoms as well as positive and negative consequences of psychosis. Internal consistency for the short form is good (range, Cronbach's α = .73 to .86). The 6-month test-retest reliability is between ρ = .66 to .84.
Self-esteem. Self-esteem was measured with the 10-item Rosenberg scale. 56 The psychometric properties of the scale are good. 57 World Health Organization Quality of Life. The World Health Organization Quality of Life (WHOQOL)-BREF 58 indexes quality of life along 4 domains: physical health, psychological health, social relationships, and environment. For the present study, the total score was used. . 59 The internal consistency of the BCIS is adequate.
59,60
Results
Baseline characteristics of the sample are displayed in table 1. The sample did not differ on most aspects.
However, positive symptoms were more prominent in the CogPack condition.
As has been presented elsewhere, patients in the MCT+ condition improved more than controls on the PSYRATS delusion score at T1 (per protocol analyses only: F(1,72) = 5.89, P = .02, η p 8 2 0 0 = . ), the PANSS delusion score (F(1,72) = 5.19, P = .03, η p 2 0 07 = . ) and there was a significant difference in favor of MCT+ regarding the BCIS self-reflectiveness increase at T1 (F(1,72) = 6.16, P = .02, η p 8 2 0 0 = . ). At T2, there were no significant differences between the 2 groups in any of the psychopathology, reasoning or other variables (all P > .30).
At post, SUSE scores were available for 79 patients (MCT+: n = 42, 91%; CogPack: n = 37, 80%; overall retention: 86%) and submitted to a 5 × 2 × 2 ANOVA with SUSE Subscales (biographical integration, positive experience of symptoms, negative experience of symptoms, positive consequences of psychosis, negative consequences of psychosis) and Time (baseline, post) as the within-subject factors and Group (MCT+, CogPack) as the between-subject factor. We will confine presentation of results to significant effects. The main effect of SUSE subscales was significant, F(4,296) = 44.76, P < .001, η partial 8 2 0 37 = .
. The negative (subjective) consequences subscale was endorsed less often than all other subscales (P < .001). Subsidiary analyses on subscale pairs indicated that there was a significant interaction between the 2 subscales of the experiences scale with Group, F(1,74) = 4.482, P = .038, η partial 2 0 057 = .
. As can be seen in figure 2 the negative appraisal of symptoms declined in the MCT+ group, while positive aspects improved at post. The opposite pattern occurred in the control group. At follow-up, SUSE scores were available for 73 patients (MCT+: n = 39, 85%; CogPack: n = 34, 74%; overall retention: 79%) and, again, submitted to a 5 × 2 × 2 ANOVA with SUSE Subscales (biographical integration, positive experience of symptoms, negative experience of symptoms, positive consequences of psychosis, negative consequences of psychosis) and Time (baseline, follow-up) as the within-subject factors and Group (MCT+, CogPack) as the between-subject factor. Again, we will confine presentation of results to significant effects. The main effect of SUSE Subscales was significant, F(4,284) = 47.87, P < .001, η partial 2 0 403 = .
. As can be seen in figure 3 , again, the negative (subjective) consequences subscale was endorsed less often than all other subscales (P < .001). In addition, symptoms were experienced as more negative than positive (P = .037).
The above effects were qualified by a 3-way interaction which yielded a significant linear contrast, F(1,71) = 4.62, P = .035, η partial 2 0 061 = .
. Subsequent analyses indicated that this was because of a significant Group × Time interaction for the negative consequences of psychosis subscale of the SUSE F(1,71) = 5.14, P = .026, η partial 2 0 067 = .
. The MCT+ group but not the control group showed a significant reduction of the negative consequences of psychosis subscale, t(38) = 2.153, P = .038, as well as an improvement on the biographical integration subscale at trend level, t(38) = 1.857, P = .071. Results remained essentially unchanged when positive symptoms were controlled for. Table 2 summarizes the demographic and clinical correlates of the SUSE subscales. Embedding psychosis in one's biography and imparting psychosis with meaning was related to higher self-reflection and IQ (biographical integration). Positive experiences with psychotic symptoms were associated with younger age (table 2) , and male gender, t(89) = 2.44, P = .017. Negative experiences of symptoms were strongly related to affective problems (in descending strength of association (absolute values): depression, low self-esteem, negative symptoms and low quality of life) and were negatively correlated with core psychotic symptoms (PANSS positive subscale) and number of admissions. For positive and negative consequences of psychosis, an inverse pattern of correlations emerged with emotional and negative symptom scales, whereby the absolute magnitude was higher for negative consequences, particularly with respect to self-esteem and quality of life where a strong negative correlation emerged. Interestingly, self-reflection correlated with positive consequences of psychosis. Suicidality as assessed with the 6 self-harm/suicidality items of the M.I.N.I. only correlated with negative consequences of psychosis (r = .22, P = .045).
Results remained essentially unchanged when positive scores (PANSS) were entered as a covariate.
Reliability
Internal consistency of SUSE subscales was satisfactory to good (biographical integration: α = .63; symptoms positive: α = .79, symptoms negative: α = .73, positive consequences of psychosis: α = .79, negative consequences of psychosis: α = .72). In contrast, test-retest reliability after 6 months was rather low (biographical integration: r = .55, P < .001; symptoms positive: r = .15, P = .216, symptoms negative: r = .48, P < .001, positive consequences of psychosis: r = .63, P < .001, negative consequences of psychosis: r = .36, P = .002).
Discussion
The present study suggests that a metacognitive intervention leads to a change in patients' attitudes towards their illness, which partially outlived the intervention period. Negative appraisals of symptoms received much higher endorsement than positive appraisals. At post, this gap was markedly narrowed in the MCT+ condition relative to the CogPack condition but this was not sustained at follow-up. This finding corroborates prior reports that patients have mixed feelings towards their symptoms 27 which is also reflected by a rather positive appraisal of the consequences of psychosis; functional/positive views (eg, " In my psychosis, I learnt a few things that I can use in life") clearly prevailed over negative attitudes (eg, "Since my psychosis, my life has lost its meaning") across time. The latter appraisal is particularly toxic in terms of emotional well-being and showed strong correlations with depression as well as low self-esteem and quality of life. It was also correlated with suicidal ideation. For this particular subscale, a marked decrease emerged in the MCT+ group at follow-up, which displayed a significant decline in pessimistic appraisals of psychosis over time, in contrast to the active control group. Of note, patients in the MCT+ condition showed a trend-level improvement in biographical integration, possibly owing to its associations with self-reflection, a secondary target of MCT, which improved selectively in the MCT+ condition across time. 44 Apart from the aforementioned correlates, we would like to highlight a very controversial finding that, if replicated, may deserve greater attention in the future and may contribute to the ongoing discussion about a defensive role of persecutory ideas and the attributional styles commonly associated with them. Although positive symptoms are usually equaled with persecutory/ fearful ideas (eg, being observed, spied on), this symptom cluster was associated with less negative experiences about symptoms at a medium effect size, in line with a theory advocated by Richard Bentall 61-63 that positive symptoms, via an external-personal attributional style for blame, 64 may serve the implicit purpose to raise self-esteem and decrease self/ideal discrepancies; psychiatry comes into play when the "fairy tale has gone bad." As of yet, evidence for the defensive model is mixed 65 and "illness gain" is a potential contributor to Note: BCIS, Beck Cognitive Insight Scale; PANSS, Positive and Negative Syndrome Scale; SUSE, Subjective Sense in Psychosis Questionnaire; WHOQOL-BREF, World Health Organization Quality of Life. *P < .05; **P < .01; ***P < .005; ****P < .001. nonadherence and therefore relevant for treatment. 66 To ignore this important aspect of positive experience may undermine the confidence of patients. Often, persecutory ideas contain an element of grandiosity (eg, being the target of an international conspiracy, possession of classified information) 67 and may be regarded as a (dysfunctional) symbolic amalgamation of the desire for appreciation/acceptance vs the adverse circumstances under which most patients live (eg, unemployment, alienation from others). For therapists, the balancing act between challenging a self-esteem-relevant, personally meaningful delusional belief and maintaining a good therapy relationship is difficult. Motive-oriented therapeutic relationship building is able to guide therapists in such critical therapeutic situations by enabling them to proactively meet their patient's needs. 68 Well-being, self-esteem and negative symptoms were correlated with negative experiences of symptoms, as well as negative consequences of the disorder.
Notwithstanding that these results are encouraging and group differences achieved significance at a medium effect size, the absolute effects were rather small, especially for meaning-making/attribution, and future efforts should be devoted to increasing their magnitude. Importantly, as shown in another publication, improvements on the SUSE obviously did not translate into long-term symptom improvement, 44 the conventional primary outcome in psychosis research. However, the recovery-discussion shows us that subjective experiences may have more influence to quality of life than symptoms reduction. 69 Follow-up studies should clarify whether improvements in the SUSE perhaps manifest in enhanced self-esteem (a re-analysis of the prior study showed a significant increase in self-esteem for MCT+ relative to the active control condition when per protocol data but not ITT data was analyzed and no covariates were entered) and lower risk for suicide in the long-term, as has been shown for the MCT group variant which yielded "sleeper effects" on self-esteem and quality of life that only emerged 3 years after the intervention. 70 A number of limitations should be brought to the reader's attention. We recommend that the SUSE might be complemented with information obtained from other sources, eg, a rating by experts and caregivers, to assess validity. Without such information it is difficult to deduce whether endorsing items such as "During my psychosis, I discovered the meaning of (my) life" or "My psychosis taught me a better and more careful treatment of myself " is something that clinicians should embrace/incorporate and support, or regard as a warning sign and maintenance factor (eg, gain from illness, suspiciousness as a coping strategy). These and the other items record "only" the subjective experience, but this point of view seems to be an important one.
Similarly, associations between SUSE scores and self-reflection, as assessed with the BCIS, should be interpreted cautiously in view of some evidence that cognitive insight is compromised in patients due to a partial (metacognitive) mismatch between subjective vs objective cognitive functioning [71] [72] [73] -although it should be noted that patients are able to assess their well-being and symptoms reliably. [74] [75] [76] Second, as noted, the study used a mid-term endpoint and some effects of improved meaning-making/ appraisal of one's condition/disorder may need time to evolve. In addition, larger sample sizes and greater diversity of patients are needed to elucidate how treatment in a psychiatric institution impacts attitudes tapped by SUSE. We can only speculate at this point that different forms of interventions yield different consequences (eg, occupational therapy may lift self-esteem in some chronic patients but may compromise self-esteem in others, particularly those with higher IQ and education, as they feel demands are too easy). We also suggest to explore SUSE in patients receiving CBT, as recovery and empowerment also represent important aims of CBT for psychosis. 77 Moreover, despite good internal consistency, test-retest reliability of SUSE subscales was rather low. Subsequent studies need to clarify whether this is the case because the construct of subjective experiences and meaning is highly volatile, or whether reliability might be improved by a different subscale composition or additional items. Finally, our results need independent replication as our findings would have not withstood a correction for multiple comparisons, especially considering the variables assessed in the original RCT.
In our view, clinical trials would benefit from integrating scales such as SUSE as outcome parameters because many patients weigh their emotional well-being as a more important treatment target than psychotic symptom reduction. 78, 79 Clinicians traditionally put emphasis on the latter aspect. 80 This neglects the ambivalence that many patients have towards their symptoms and their disorder (symptoms are predominantly experienced as negative but functional/positive attitudes receive higher endorsement than negative ones) that is also reflected in a typical decline in emotional well-being once reality distortion and insight is improved. 81 As neither biological psychiatry nor clinical psychology can offer more than small to medium effects in improving the disorder, we should refrain from demonizing psychosis thereby possibly inducing new fears, particularly angst.
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